Matthew B. Klein, CHIEF EXECUTIVE OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 2,850 shares at $70.91 ($202K) on 2026-04-21, disclosed to the SEC on 2026-04-23.
Seasonal sale ($202k) by CHIEF EXECUTIVE OFFICER — this insider has traded PTCT in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| PTCT | SELL | 2026-05-15 | $917K | — | Filing → |
| PTCT | SELL | 2026-03-13 | $171K | — | Filing → |
| PTCT | SELL | 2026-02-20 | $511K | — | Filing → |